There were 415 press releases posted in the last 24 hours and 189,646 in the last 365 days.


Please use this form to send email to PR contact of this press release:
Medical Breakthrough: CRISPR Gene Editing Technology from MIT and Harvard Phase 3: Aridis Pharmaceuticals (Nasdaq: ARDS)

Dr. Vu L. Truong CEO and Founder
Aridis Pharmaceuticals, Inc.
+1 408-385-1742


Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image